Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Comvita assures customers of UMF® quality

Media Release

14 March 2008

Comvita assures customers of UMF® quality

Comvita strongly supports recent action taken by the Active Manuka Honey Association (AMHA) to protect the UMF® (Unique Manuka Factor) brand and customers around the globe who use UMF® honey products.

This follows the announcement that a search warrant has been executed by police as part of an investigation into the alleged fraudulent activity by a senior employee of a honey company licensed to sell UMF® (Unique Manuka Factor™) honey and honey products.

Brett Hewlett, Comvita CEO says, “As the largest manufacturer and exporter of Manuka honey, we endorse AMHA’s strong action to preserve the integrity of the UMF® brand in New Zealand; and also the wider action taken in key offshore markets. The credibility of the brand is of paramount importance, not only to our business but to the New Zealand beekeeping industry as a whole.”

UMF® is a special antibacterial activity not found in other honeys, making UMF® Manuka Honey one of the most sought after honeys in the world. It is taken internally to assist the digestive function and on wounds to support natural healing and immune response.  Licensed users of the UMF® brand are required to meet set criteria which include regular monitoring and auditing in order to ensure premium quality.

“All Comvita UMF® honey products are independently tested and certified to have the special UMF antibacterial property level as indicated on the label. Very high quality standards have been set” says Hewlett.

Comvita’s Active UMF®15+ Manuka honey was named “Best Manuka” in the latest issue of the BBC’s Good Food Magazine; the UK publication tested over 40 honeys to find the best.

-Ends-

 

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.